| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Groenewald Ferdinand | Interim CFO | C/O BIOSIG TECHNOLOGIES, INC., 12424 WILSHIRE BLVD STE 745, LOS ANGELES | /s/ Ferdinand Groenewald | 2025-06-02 | 0001734018 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSGM | Common Stock | Award | $0 | +175K | +291.67% | $0.00 | 235K | May 29, 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The shares of common stock were granted under the Company's 2023 Equity Incentive Plan and were fully vested as of May 29, 2025 (the "Date of Grant"), based on a closing price of $5.05 per share on such date. |